Lumida
/SI
⌘K
Shoulder Innovations Inc

Shoulder Innovations Inc

SI
$21.59USD↓-4.17%-0.94 today

MARKET CAP

447.7M

P/E (TTM)

8.4x

FWD P/E

—

DAY RANGE

$21 – $23

52W RANGE

$1
$23

AI Summary

Stalk
StalkMedium

The stock remains in a high-confidence Stage 2 uptrend following a clear breakout and continuation patterns, supported by rising EMAs and expanding volume. However, short-term conditions are extended and overbought, suggesting deferred entry until a healthier pullback into the 9/21 EMA support zone.

  • ↑Q1 2026 revenue of $16.7M (+65% YoY); full-year guide $65–68M (+37–44%)
  • ↑Sole public pure-play in $2.8B shoulder arthroplasty market, supporting niche moat
  • ↓Q1 net loss of $8.4M vs $4.7M prior year; SG&A at $18.2M due to headcount and public costs
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Shoulder Innovations, Inc. (NASDAQ: SI) is a pioneering medical technology company focused on shoulder surgical care, specifically in shoulder arthroplasty. Positioned within a lucrative $2.8 billion global market, Shoulder Innovations has taken a unique stand as the only public entity dedicated exclusively to this niche field. The company harnesses advanced technologies and an evolving product portfolio to address surgical limitations, thereby catering to a growing customer base. Their robust commercial strategy and commitment to innovation streamline growth and enhance market share within the orthopedic sector.

Bull says

  • ↑Q1 2026 revenue of $16.7M (+65% YoY); full-year guide $65–68M (+37–44%)
  • ↑Sole public pure-play in $2.8B shoulder arthroplasty market, supporting niche moat
  • ↑Surgeon base grew 61% YoY to 134 core/contender surgeons, driving utilization
  • ↑Q1 gross margin at 77.7% with $108.5M cash bolstering investments
  • ↑Launched I-135 RFX and advancing robotics, addressing unmet clinical needs
  • ↑Positive factor signals reflect strong growth potential and quality profile

Bear says

  • ↓Q1 net loss of $8.4M vs $4.7M prior year; SG&A at $18.2M due to headcount and public costs
  • ↓Legal and litigation expenses elevated operating burn, pressuring profitability
  • ↓Sustained surgeon adoption needed amid pricing pressures and rising competition
  • ↓Execution risk on new product launches could derail revenue trajectories
  • ↓Dynamic market shifts and reimbursement changes may dampen demand
  • ↓Negative factor signals from weak profitability and earnings yield raise sustainability concerns

Earnings Call · Q3 2022 · Mgmt. Guidance

Updated 07-03-2026neutral

Transcript signals

Bull points

  • Silvergate reported strong third quarter results, even as the broader digital asset ecosystem continued to experience challenges. Against this backdrop, Silvergate delivered record net income available to common shareholders of $40.6 million, an increase of 13% compared to the second quarter, driven by our diverse revenue streams and progress on our strategic initiatives.
  • 1,677 in the third quarter, an increase of over 350 customers since the same quarter last year. We added over 90 clients on a sequential basis as we continue our focus on adding high-quality clients that bring the most value to our platform.
  • 9% to $1.5 billion compared to $1.4 billion at the end of the second quarter. In addition, we experienced a range of outstanding SendLeverage balances during the quarter between $268 million and $322 million, with an average outstanding balance of $308 million.

Bear points

  • The SEND saw lower daily trading volumes this quarter, with transfer volume of $113 billion, a decrease of 41% on a sequential basis. Volumes were mainly impacted by trends in the broader industry, specifically within stablecoins.
  • Unfortunately, we no longer expect that to happen this year.
  • average digital asset customer deposits were $12 billion in the quarter, down 13% compared to last quarter.
Read full transcript analysis ›